Xtx Topco LTD Royalty Pharma PLC Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $344,425 - $425,412	11,636 Added 125.46%	20,911 $642,000
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $97,359 - $117,057	-2,971 Reduced 24.26%	9,275 $334,000
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $236,939 - $266,397	6,049 Added 97.61%	12,246 $483,000
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $247,136 - $276,696	6,197 New	6,197 $249,000
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $385,088 - $436,283	-10,280 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$35.17 - $42.48 $361,547 - $436,694	10,280 New	10,280 $410,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.